Koninklijke Philips ROE 2010-2024 | PHG
Koninklijke Philips ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-06-30 | $-0.05B | $12.84B | -0.81% |
2023-09-30 | $-0.56B | -7.76% | |
2023-06-30 | $-0.48B | $13.26B | -4.39% |
2023-03-31 | $-0.33B | -3.10% | |
2022-06-30 | $0.66B | $15.71B | 4.74% |
2021-06-30 | $0.68B | $14.44B | 5.08% |
2020-06-30 | $0.78B | $12.09B | 5.70% |
2019-06-30 | $1.23B | $13.41B | 8.56% |
2018-06-30 | $1.37B | $13.96B | 9.45% |
2017-06-30 | $1.84B | $15.12B | 12.73% |
2016-12-31 | $1.60B | $14.95B | 11.58% |
2016-09-30 | $0.87B | $13.91B | 6.52% |
2016-06-30 | $0.81B | $13.94B | 6.21% |
2016-03-31 | $0.64B | $12.59B | 4.99% |
2015-12-31 | $0.72B | $13.08B | 5.55% |
2015-09-30 | $0.94B | $12.86B | 7.05% |
2015-06-30 | $0.44B | $12.73B | 3.24% |
2015-03-31 | $0.48B | $12.98B | 3.34% |
2014-12-31 | $0.55B | $14.58B | 3.74% |
2014-09-30 | $0.94B | $14.60B | 6.31% |
2014-06-30 | $1.45B | $14.76B | 9.77% |
2014-03-31 | $1.53B | $15.11B | 10.44% |
2013-12-31 | $1.55B | $14.91B | 10.66% |
2013-09-30 | $0.52B | $14.51B | 3.59% |
2013-06-30 | $0.37B | $14.11B | 2.51% |
2013-03-31 | $0.16B | $14.79B | 1.04% |
2012-12-31 | $0.27B | $14.37B | 1.76% |
2012-09-30 | $0.54B | $15.12B | 3.36% |
2012-06-30 | $0.42B | $15.65B | 2.50% |
2012-03-31 | $-1.72B | $16.11B | -9.74% |
2011-12-31 | $-1.85B | $17.26B | -10.01% |
2011-09-30 | $-1.00B | $18.32B | -5.25% |
2011-06-30 | $-0.43B | $18.87B | -2.19% |
2011-03-31 | $1.84B | $19.31B | 9.18% |
2010-12-31 | $1.91B | $20.04B | 9.46% |
2010-09-30 | $1.67B | $20.43B | 8.21% |
2010-06-30 | $1.25B | $20.16B | 6.23% |
2010-03-31 | $0.98B | $20.32B | 5.02% |
2009-12-31 | $0.63B | $20.35B | 3.24% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $30.774B | $19.663B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
Stryker (SYK) | United States | $137.290B | 32.08 |
Boston Scientific (BSX) | United States | $122.743B | 37.38 |
Medtronic (MDT) | Ireland | $114.552B | 17.05 |
EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
ResMed (RMD) | United States | $35.117B | 30.92 |
Terumo (TRUMY) | Japan | $28.517B | 40.27 |
Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
Baxter (BAX) | United States | $19.851B | 13.46 |
Insulet (PODD) | United States | $16.269B | 68.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
ICU Medical (ICUI) | United States | $4.261B | 40.67 |
Haemonetics (HAE) | United States | $4.084B | 20.20 |
TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
Neogen (NEOG) | United States | $3.599B | 37.75 |
Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
Envista Holdings (NVST) | United States | $3.398B | 18.13 |
QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
Warby Parker (WRBY) | United States | $1.614B | 0.00 |
AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
InMode (INMD) | Israel | $1.464B | 9.32 |
AtriCure (ATRC) | United States | $1.372B | 0.00 |
Owens & Minor (OMI) | United States | $1.247B | 9.63 |
Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
Evolus (EOLS) | United States | $1.006B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.64 |
Quanterix (QTRX) | United States | $0.489B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
Jin Medical (ZJYL) | China | $0.439B | 0.00 |
ZimVie (ZIMV) | United States | $0.435B | 40.41 |
Valneva SE (VALN) | France | $0.432B | 0.00 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
Biote (BTMD) | United States | $0.307B | 14.18 |
Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Zynex (ZYXI) | United States | $0.257B | 45.00 |
Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
Omeros (OMER) | United States | $0.227B | 0.00 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 67.33 |
FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
Brainsway (BWAY) | Israel | $0.135B | 161.40 |
TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.111B | 11.44 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.62 |
Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.30 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |